Literature DB >> 6176016

Studies on the defect in cell-mediated immunity in lepromatous leprosy using HLA-D-identical siblings. Absence of circulating suppressor cells and evidence that the defect is in the T-lymphocyte, rather than the monocyte, population.

G L Stoner, R N Mshana, J Touw, A Belehu.   

Abstract

Sixteen healthy siblings were identified as HLA-D-identical to 12 borderline lepromatous or polar lepromatous leprosy patients by the absence of a mixed lymphocyte reaction (MLR). The peripheral blood mononuclear cells (PBM) of the healthy siblings showed a lymphoproliferative response (delta cpm) to Mycobacterium leprae antigens which was about fivefold or more greater than that of the lepromatous patients. Lepromatous PBM, with or without mitomycin C treatment, were co-cultured with a constant number of normal PBM. In other experiments the two cell types were co-cultured in various proportions, with the total cell number kept constant. Neither approach revealed suppressor cells in lepromatous PBM capable of suppressing the lymphoproliferative response to M. leprae. On the contrary, we found that lepromatous PBM can respond to M. leprae antigens if the sensitized lymphocyte is provided by mitomycin-C treated normal PBM. Additionally, experiments in which isolated adherent cells and non-adherent cells of sibling pairs were recombined failed to reveal a defect in the M. leprae antigen-presenting function of lepromatous adherent cells. Since we found no evidence that sensitized cells are present in lepromatous PBM with their function unexpressed (due to a monocyte defect) or suppressed (due to suppressor cells), we conclude that lepromatous patients simply lack sufficient numbers of antigen-specific T lymphocytes to initiate a lymphoproliferative response to M. leprae antigens. The reason for their absence remains an important unanswered question.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6176016     DOI: 10.1111/j.1365-3083.1982.tb00619.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  8 in total

1.  Natural emergence of antigen-reactive T cells in lepromatous leprosy patients during erythema nodosum leprosum.

Authors:  S Laal; L K Bhutani; I Nath
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

2.  The role of products of the human HLA-DR locus (Ia molecules) in in vitro M. leprae driven lymphoproliferation.

Authors:  A Haregewoin; T Yemaneberhan; A Belehu
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

3.  In vitro suppression of interleukin 2 production by Mycobacterium leprae antigen.

Authors:  S Makonkawkeyoon; W Kasinrerk
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

4.  Suppression of delayed hypersensitivity skin reactions to tuberculin by M. leprae antigens in patients with lepromatous and tuberculoid leprosy.

Authors:  U Sengupta; S Sinha; G Ramu; J Lamb; J Ivanyi
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

5.  Monocyte-derived soluble suppressor factor(s) in patients with lepromatous leprosy.

Authors:  M Sathish; L K Bhutani; A K Sharma; I Nath
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

Review 6.  Suppressor cell activity and phenotypes in the blood or tissues of patients with leprosy.

Authors:  T H Rea
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

7.  An analysis of in vitro T cell responsiveness in lepromatous leprosy.

Authors:  G Kaplan; D E Weinstein; R M Steinman; W R Levis; U Elvers; M E Patarroyo; Z A Cohn
Journal:  J Exp Med       Date:  1985-09-01       Impact factor: 14.307

8.  Phenolic glycolipid-I of Mycobacterium leprae induces general suppression of in vitro concanavalin A responses unrelated to leprosy type.

Authors:  H K Prasad; R S Mishra; I Nath
Journal:  J Exp Med       Date:  1987-01-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.